About Us Contact Us Sitemap

Sacral Neuromodulation Market, By Product Type (External/Non-Implantable Pulse Generators (EPGs), Lead Electrodes, Implantable Pulse Generators (IPGs), and Accessories and System Components), By Application, By End User, By Patient Age Group, By Technology, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Market Research Image
Report ID AV4789
Published Date February 2026
Pages 374
Industry Healthcare
Format PPT/PDF
Base Year 2025
Historical Data 2019-2024
Delivery Timeline 24 Hour

REPORT HIGHLIGHT

Sacral Neuromodulation market size was valued at US$ 1,987.87 Million in 2024, expanding at a CAGR of 11.51% from 2025 to 2032.

Sacral neuromodulation (SNM) is a medical therapy that delivers electrical pulses to stimulate the sacral nerves, helping restore normal communication between the pelvic organs and the brain. This treatment is used for patients with conditions such as overactive bladder, urinary urge incontinence, non-obstructive urinary retention, and fecal incontinence, particularly when standard therapies—like behavioral interventions and medications—prove ineffective. The procedure begins with a temporary testing phase to assess the patient’s response to stimulation. Patients who show significant symptom improvement during this phase may then receive a permanently implanted neurostimulator system for long-term symptom management.

Globally, governments are increasingly supporting neuromodulation therapies as part of their healthcare initiatives. For example, the U.S. Centers for Medicare & Medicaid Services (CMS) provides coverage for SNM procedures, while the European Union has included neuromodulation devices in various health technology assessment programs to improve accessibility and patient outcomes. This governmental support contributes to broader adoption and market growth worldwide.

Sacral Neuromodulation Market- Market Dynamics

Rising Awareness and Enhanced Reimbursement Pathways

The sacral neuromodulation market is experiencing significant growth driven by two key factors: increased awareness among physicians and patients, and improved reimbursement pathways. Enhanced education and training programs, coupled with stronger clinical evidence, have led to earlier diagnosis and greater acceptance of neuromodulation therapies for bladder and bowel disorders. The inclusion of sacral neuromodulation in urology and gastroenterology treatment guidelines has further boosted physician confidence and referral rates. At the same time, clearer reimbursement frameworks and expanded insurance coverage—particularly in North America and select European countries—have reduced out-of-pocket expenses for patients undergoing device implantation and follow-up treatment. Globally, government healthcare authorities also support adoption; for example, the U.S. Centers for Medicare & Medicaid Services (CMS) reimburses sacral neuromodulation procedures for certain indications, while several European national health systems provide partial or full coverage, which enhances patient access and encourages wider use. The synergy of heightened awareness, strong clinical support, and favorable reimbursement has accelerated adoption, reinforced the therapy’s role as standard care for refractory conditions, and is driving sustained market growth.

Sacral Neuromodulation Market- Segmentation Analysis:
By Product Type

In 2024, the Implantable Pulse Generators (IPGs) segment is expected to dominate the global sacral neuromodulation devices market, driven by the critical role these devices play in therapy delivery. IPGs provide controlled electrical pulses to the sacral nerves, which are essential for treating pelvic floor disorders such as overactive bladder, fecal incontinence, and urinary retention. The demand for IPGs is directly linked to the growing adoption of sacral neuromodulation treatments, which have demonstrated significant clinical efficacy and contribute substantially to industry revenue. According to the U.S. National Institutes of Health (NIH), pelvic floor disorders affect nearly 25% of adult women in the United States, highlighting a significant patient population that benefits from neuromodulation therapies and underlining the market potential for IPG devices.

Technological advancements in IPG design further support market growth by improving patient outcomes and comfort. Modern IPGs feature smaller, more compact designs, extended battery life, MRI compatibility, and programmable capabilities, which enhance usability for both patients and clinicians. These improvements increase patient adherence to therapy, reduce device replacements, and encourage repeat adoption, driving sustained revenue growth for the segment. The U.S. Food and Drug Administration (FDA) reports a steady increase in approvals for next-generation neuromodulation devices, reflecting ongoing innovation and regulatory support for safer and more effective IPG technologies.

Sacral Neuromodulation Market- Geographical Insights

North America is projected to lead the Sacral Neuromodulation market throughout the forecast period. Market growth is primarily driven by the high prevalence of urinary and fecal incontinence, along with other pelvic floor disorders, which create a sustained demand for effective neuromodulation therapies. The region benefits from a well-developed healthcare infrastructure, with numerous medical facilities offering advanced treatment options and established clinical protocols for sacral nerve stimulation procedures. In addition, the United States and Canada provide improved reimbursement frameworks and expanded insurance coverage, reducing financial barriers for patients and healthcare providers, thereby enhancing the accessibility and affordability of sacral neuromodulation treatments. Globally, governments are also promoting neuromodulation therapies: for example, the U.S. Centers for Medicare & Medicaid Services (CMS) reimburses sacral neuromodulation procedures for eligible patients, while several European countries, including Germany, France, and the U.K., have integrated sacral neuromodulation into national health coverage plans, which further supports adoption worldwide. The presence of major device manufacturers, combined with ongoing technological advancements in implantable neuromodulation systems—including extended battery life and advanced programming capabilities—has increased physician adoption and patient acceptance, further driving revenue growth in the North American market.

Sacral Neuromodulation Market- Competitive Landscape:

The sacral neuromodulation market is highly competitive, with three major medtech companies—Medtronic, Axonics, and Boston Scientific—dominating, while other established players, including Abbott and several regional device manufacturers, actively compete. Market competition is primarily driven by three factors: technological innovation, distribution strength, and clinical support. Technological differentiation includes MRI-safe, smaller, rechargeable or non-rechargeable implantable pulse generators, improved leads, and advanced programming software. Strong distribution networks and comprehensive clinical support facilitate physician adoption of new technologies. Legal and intellectual property disputes between companies have also shaped the market landscape, with recent court decisions influencing competition and market access. Market dynamics continue to evolve through new product approvals, strategic mergers and acquisitions, and partnerships, while rapidly growing Asian markets are increasingly accessible to both established global players and agile local competitors.

Recent Developments:

  • In June 2025, Neuspera® Medical, Inc., a leading developer of integrated neuromodulation technologies, received U.S. Food and Drug Administration (FDA) approval for its integrated sacral neuromodulation (iSNM) system for treating urinary urge incontinence (UUI).

  • In May 2025, Medtronic launched its next-generation InterStim X system, featuring advanced wireless programming and extended battery life, significantly enhancing patient convenience and treatment outcomes.

SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BioControl Medical
  • Uroplasty Inc.
  • Cogentix Medical Inc.
  • Cyberonics Inc.
  • Nuvectra Corporation
  • Nevro Corp.
  • Synapse Biomedical Inc.
  • ImThera Medical Inc.
  • Abbott Laboratories
  • Advanced Bionics AG
  • Stryker Corporation
  • Inspire Medical Systems Inc.
  • Laborie Medical Technologies
  • MicroTransponder Inc.
  • Brainsway Ltd.
  • EndoStim Inc.
  • Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • External/Non-Implantable Pulse Generators (EPGs)
  • Lead Electrodes
  • Implantable Pulse Generators (IPGs)
  • Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Urinary Incontinence
  • Urinary Retention
  • Fecal Incontinence
  • Overactive Bladder
  • Chronic Pelvic Pain and Relative Pelvic Pain
  • Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Large Medical Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Adult
  • Pediatric
  • Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Rechargeable Systems
  • Non-Rechargeable Systems
  • Wired/Lead Systems vs Wireless/Leadless Systems
  • Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Sacral Neuromodulation Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Sacral Neuromodulation Market Snippet by Product Type
2.1.2. Sacral Neuromodulation Market Snippet by Application
2.1.3. Sacral Neuromodulation Market Snippet by End User
2.1.4. Sacral Neuromodulation Market Snippet by Patient Age Group
2.1.5. Sacral Neuromodulation Market Snippet by Technology
2.1.6. Sacral Neuromodulation Market Snippet by Country
2.1.7. Sacral Neuromodulation Market Snippet by Region
2.2. Competitive Insights
3. Sacral Neuromodulation Key Market Trends
3.1. Sacral Neuromodulation Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Sacral Neuromodulation Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Sacral Neuromodulation Market Opportunities
3.4. Sacral Neuromodulation Market Future Trends
4. Sacral Neuromodulation Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Sacral Neuromodulation Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Sacral Neuromodulation Market Landscape
6.1. Sacral Neuromodulation Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Sacral Neuromodulation Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. External/Non-Implantable Pulse Generators (EPGs)
7.1.3. Lead Electrodes
7.1.4. Implantable Pulse Generators (IPGs)
7.1.5. Accessories and System Components
8. Sacral Neuromodulation Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Urinary Incontinence
8.1.3. Urinary Retention
8.1.4. Fecal Incontinence
8.1.5. Overactive Bladder
8.1.6. Chronic Pelvic Pain and Relative Pelvic Pain
8.1.7. Others
9. Sacral Neuromodulation Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospitals and Large Medical Centers
9.1.3. Ambulatory Surgical Centers
9.1.4. Specialty Clinics
9.1.5. Research and Academic Institutes
10. Sacral Neuromodulation Market – By Patient Age Group
10.1. Overview
10.1.1. Segment Share Analysis, By Patient Age Group, 2024 & 2032 (%)
10.1.2. Adult
10.1.3. Pediatric
10.1.4. Geriatric
11. Sacral Neuromodulation Market – By Technology
11.1. Overview
11.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
11.1.2. Rechargeable Systems
11.1.3. Non-Rechargeable Systems
11.1.4. Wired/Lead Systems vs Wireless/Leadless Systems
11.1.5. Trial Systems vs Permanent Systems
12. Sacral Neuromodulation Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Sacral Neuromodulation Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Sacral Neuromodulation Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Sacral Neuromodulation Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Sacral Neuromodulation Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Sacral Neuromodulation Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Patient Age Group, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Sacral Neuromodulation Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. BioControl Medical
13.2.2. Uroplasty Inc.
13.2.3. Cogentix Medical Inc.
13.2.4. Cyberonics Inc.
13.2.5. Nuvectra Corporation
13.2.6. Nevro Corp.
13.2.7. Synapse Biomedical Inc.
13.2.8. ImThera Medical Inc.
13.2.9. Abbott Laboratories
13.2.10. Advanced Bionics AG
13.2.11. Stryker Corporation
13.2.12. Inspire Medical Systems Inc.
13.2.13. Laborie Medical Technologies
13.2.14. MicroTransponder Inc.
13.2.15. Brainsway Ltd.
13.2.16. EndoStim Inc.
13.2.17. Stimwave LLC
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SACRAL NEUROMODULATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BioControl Medical
  • Uroplasty Inc.
  • Cogentix Medical Inc.
  • Cyberonics Inc.
  • Nuvectra Corporation
  • Nevro Corp.
  • Synapse Biomedical Inc.
  • ImThera Medical Inc.
  • Abbott Laboratories
  • Advanced Bionics AG
  • Stryker Corporation
  • Inspire Medical Systems Inc.
  • Laborie Medical Technologies
  • MicroTransponder Inc.
  • Brainsway Ltd.
  • EndoStim Inc.
  • Stimwave LLC

GLOBAL SACRAL NEUROMODULATION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • External/Non-Implantable Pulse Generators (EPGs)
  • Lead Electrodes
  • Implantable Pulse Generators (IPGs)
  • Accessories and System Components

GLOBAL SACRAL NEUROMODULATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Urinary Incontinence
  • Urinary Retention
  • Fecal Incontinence
  • Overactive Bladder
  • Chronic Pelvic Pain and Relative Pelvic Pain
  • Others

GLOBAL SACRAL NEUROMODULATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Large Medical Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research and Academic Institutes

GLOBAL SACRAL NEUROMODULATION MARKET, BY PATIENT AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Adult
  • Pediatric
  • Geriatric

GLOBAL SACRAL NEUROMODULATION MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Rechargeable Systems
  • Non-Rechargeable Systems
  • Wired/Lead Systems vs Wireless/Leadless Systems
  • Trial Systems vs Permanent Systems

GLOBAL SACRAL NEUROMODULATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Request For Sample
Choose License Type
assit assit
Related Reports

Credibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

ISO Certification ISO 9001:2015
ESOMAR Individual ESOMAR Corporate
GDPR Compliance GDPR Compliance
D-U-N-S Registered D-U-N-S Registered
BBB Accreditation BBB Accreditation
MRS MRS
CONTACT INFORMATION

Email:

[email protected]

U.S. Office

11923 NE Sumner St STE 750924
Portland, Oregon, 97220, USA

Asia Pacific Office

4, Rohan Business Centre, Paud Road,
Kothrud, Pune Maharashtra, 411038, India

QUICK LINKS
RESOURCES
Secure Payment By
PayPal
Visa
MasterCard
American Express
Support Hours

We’re here to assist you around the clock, six days a week.

Monday – Friday: 10:00 AM to 6:00 PM

Saturday: 10:00 AM to 3:00 PM

Sunday: Closed

© Copyright 2026 Analystview Market Insights | All Rights Reserved